Evidence map›Paper›PMID 8993863›Full record

ReviewClinical microbiology reviews1997

PCR in laboratory diagnosis of human Borrelia burgdorferi infections.

B L Schmidt

Open access · bronzeAbstract readComparative StudyReview
In one paragraph

Review in Clinical microbiology reviews, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 169 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Life (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Lyme Disease Frontiers: ReconcilingPathogens (Basel, Switzerland) · 2019
    Review
  9. Article
  10. History of Morgellons disease: from delusion to definition.Clinical, cosmetic and investigational dermatology · 2018
    Review
  11. Article
  12. Morgellons disease: a filamentous borrelial dermatitis.International journal of general medicine · 2016
    Review
  13. Article
  14. Article
  15. Culture and identification ofF1000Research · 2014
    Article
  16. Review
  17. Article
  18. Novel Diagnosis of Lyme Disease: Potential for CAM Intervention.Evidence-based complementary and alternative medicine : eCAM · 2009
    Article
  19. Article
  20. Emerging pathogens: challenges and successes of molecular diagnostics.The Journal of molecular diagnostics : JMD · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

B L SchmidtLudwig Boltzmann Institute for Dermato-Venerological Serodiagnosis, Hospital of Vienna-Lainz, Vienna, Austria.
Klinik Hietzing · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The laboratory diagnosis of Lyme borreliosis, the most prevalent vector-borne disease in the United States and endemic in parts of Europe and Asia, is currently based on serology with known limitations. Direct demonstration of Borrelia burgdorferi by culture may require weeks, while enzyme-linked immunosorbent assays for antigen detection often lack sensitivity. The development of the PCR has offered a new dimension in the diagnosis. Capable of amplifying minute amounts of DNA into billions of copies in just a few hours, PCR facilitates the sensitive and specific detection of DNA or RNA of pathogenic organisms. This review is restricted to applications of PCR methods in the diagnosis of human B. burgdorferi infections. In the first section, methodological aspects, e.g., sample preparation, target selection, primers and PCR methods, and detection and control of inhibition and contamination, are highlighted. In the second part, emphasis is placed on diagnostic aspects, where PCR results in patients with dermatological, neurological, joint, and ocular manifestations of the disease are discussed. Here, special attention is given to monitoring treatment efficacy by PCR tests. Last, specific guidelines on how to interpret PCR results, together with the advantages and limitations of these new techniques, are presented.

Indexed as

Borrelia burgdorferi GroupDNA PrimersDrug MonitoringEye DiseasesHumansJoint DiseasesLyme DiseaseNervous System DiseasesPolymerase Chain ReactionSensitivity and SpecificitySerologic TestsSkin DiseasesSpecimen HandlingDNA Primers

Identifiers

PMID8993863
PMCPMC172948
OpenAlexW2133943017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.